# Virology Follow up Study in Subjects Previously Treated With Telaprevir

> **NCT00916474** · — · COMPLETED · sponsor: **Vertex Pharmaceuticals Incorporated** · enrollment: 408 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** telaprevir

## Key facts

- **NCT ID:** NCT00916474
- **Lead sponsor:** Vertex Pharmaceuticals Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 408 (ACTUAL)
- **Last updated:** 2014-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00916474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00916474, "Virology Follow up Study in Subjects Previously Treated With Telaprevir". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00916474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*